摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-hydroxy-N-[2-hydroxy-3-(4-{5-[5-(isopropylamino-methyl)-4-methyl-thiophene-2-yl]-[1,2,4]oxadiazol-3-yl}-2,6-dimethyl-phenoxy)-propyl]-ethanamide | 1160954-28-8

中文名称
——
中文别名
——
英文名称
2-hydroxy-N-[2-hydroxy-3-(4-{5-[5-(isopropylamino-methyl)-4-methyl-thiophene-2-yl]-[1,2,4]oxadiazol-3-yl}-2,6-dimethyl-phenoxy)-propyl]-ethanamide
英文别名
2-hydroxy-N-[2-hydroxy-3-(4-{5-[5-(isopropylamino-methyl)-4-methyl-thiophen-2-yl]-[1,2,4]oxadiazol-3-yl}-2,6-dimethyl-phenoxy)-propyl]-ethanamide;2-hydroxy-N-[2-hydroxy-3-(4-{5-[5-(isopropylamino-methyl)-4-methyl-thiophen-2-yl]-[1,2,4]oxadiazol-3-yl}-2,6-dimethyl-phenoxy)-propyl]-acetamide;N-[3-[2,6-dimethyl-4-[5-[4-methyl-5-[(propan-2-ylamino)methyl]thiophen-2-yl]-1,2,4-oxadiazol-3-yl]phenoxy]-2-hydroxypropyl]-2-hydroxyacetamide
2-hydroxy-N-[2-hydroxy-3-(4-{5-[5-(isopropylamino-methyl)-4-methyl-thiophene-2-yl]-[1,2,4]oxadiazol-3-yl}-2,6-dimethyl-phenoxy)-propyl]-ethanamide化学式
CAS
1160954-28-8
化学式
C24H32N4O5S
mdl
——
分子量
488.608
InChiKey
ZRVXUIOXNYUQGY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    34
  • 可旋转键数:
    11
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    158
  • 氢给体数:
    4
  • 氢受体数:
    9

文献信息

  • THIOPHENE DERIVATIVES AS AGONISTS OF S1P1/EDG1
    申请人:Bolli Martin
    公开号:US20100261702A1
    公开(公告)日:2010-10-14
    The invention relates to novel thiophene derivatives (1), their preparation and their use as pharmaceutically active compounds.Said compounds particularly act as immunomodulating agents. Formula (I).
    这项发明涉及新型噻吩生物(1),它们的制备以及它们作为药用活性化合物的用途。这些化合物特别作为免疫调节剂。公式(I)。
  • NOVEL THIOPHENE DERIVATIVES AS AGONISTS OF S1P1/EDG1
    申请人:Actelion Pharmaceuticals Ltd.
    公开号:EP2222667A2
    公开(公告)日:2010-09-01
  • US8148410B2
    申请人:——
    公开号:US8148410B2
    公开(公告)日:2012-04-03
  • [EN] NOVEL THIOPHENE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DU THIOPHÈNE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2009074950A2
    公开(公告)日:2009-06-18
    The invention relates to novel thiophene derivatives (l), their preparation and their use as pharmaceutically active compounds.Said compounds particularly act as immunomodulating agents. Formula (I).
查看更多